Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts HTG Molecular Diagnostics (HTGM) at Overweight
-
UPDATE: Cantor Fitzgerald Starts T2 Biosystems, Inc (TTOO) at Overweight
-
R1 RCM to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Lantheus Holdings to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Aurinia to Participate in Upcoming Investor Conferences
-
Merit Medical to Present at Three Upcoming Conferences
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Tactile Medical to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
-
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Evofem Biosciences to Present at Upcoming Investor Conferences
-
Verseon unveils new blockchain technology
-
WellCare Health Plans (WCG) PT Raised to $330 at Cantor Fitzgerald After Updating Numbers to Reflect Meridian Closing
-
VBL Therapeutics to Present at Upcoming Conferences in October
-
ProPhotonix Announces Deregistration of PPIR Line
-
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
-
Foamix (FOMX) Prices 11.67M Share Follow-On Offering at $6/Sh
-
Foamix Announces Pricing of its Follow-on Offering of Ordinary Shares
-
Corbus Pharmaceuticals (CRBP) PT Raised to $36 at Cantor Fitzgerald as Lenabasum's Gain, Following Tocilizumab's Loss
-
UPDATE: Cantor Fitzgerald Starts LHC Group (LHCG) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Amedisys (AMED) at Neutral
-
Foamix (FOMX) Announces Proposed Follow-On Share Offering
-
Foamix Announces Proposed Follow-on Offering of Ordinary Shares
-
Cantor Fitzgerald Starts Addus HomeCare (ADUS) at Overweight
-
Cerner (CERN) Executive Departure 'Not Concerning' - Cantor Fitzgerald
-
Cantor Fitzgerald Maintains Bullish View on PolarityTE (COOL) Post Q3
-
Cantor Fitzgerald Positive on Evolent Health (EVH) New Century Health Acquisition, Raises PT Raised to $37
-
Cantor Fitzgerald Downgrades Vital Therapies (VTL) to Neutral
-
Pacific Bio (PACB) Prices 14.12M Share Common Offering at $4.25/Sh
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Emergent BioSolutions (EBS) PT Raised to $68 at Cantor Fitzgerald
-
PCI Pharma Services to Acquire Sherpa Clinical Packaging
-
Advaxis Announces Closing of Its Public Offering of Common Stock and Warrants
-
Cantor Fitzgerald Starts Krystal Biotech (KRYS) at Overweight
-
Pacific Bio (PACB) Proposed Public Offering of Common Stock
-
KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
-
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
-
Ideanomics Appoints Brett McGonegal Co-CEO, adds other Senior Executives
-
"Instant Family" Actress, Rose Byrne, to Represent Happy Trails for Kids at 2018 Cantor Fitzgerald Charity Day
-
Cantor Fitzgerald Starts Aridis Pharmaceuticals (ARDS) at Overweight
-
Global Lyme Alliance to Participate in 2018 Cantor Fitzgerald Charity Day
-
Quality Systems (QSII) PT Raised to $26 at Cantor Fitzgerald
-
Advaxis (ADXS) Prices 16.67M Shares Offering
-
Pre-Open Movers 09/07: (OKTA) (FIVE) (MRVL) Higher; (EGAN) (TSLA) (HOME) Lower (more...)

